Organon acquires Karolinska Development’s portfolio company Forendo Pharma at a total purchase price of USD 945 million provided fulfilment of all milestones
Go back to Organon acquires Karolinska Development’s portfolio company Forendo Pharma at a total purchase price of USD 945 million provided fulfilment of all milestones| Merck & Co. (NYSE: MRK) | Delayed: 146.87 -0.28 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.15 | 52 Week High | $65.46 | |||
| Open | $147.08 | 52 Week Low | $47.97 | |||
| Day High | $147.84 | P/E | 99.91 | |||
| Day Low | $145.74 | EPS | $1.47 | |||
| Volume | 31,159,364 | |||||
| (NYSE: OGN) | Delayed: 13.68 -0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.69 | 52 Week High | $8.00 | |||
| Open | $13.68 | 52 Week Low | $8.00 | |||
| Day High | $13.70 | P/E | N/A | |||
| Day Low | $13.68 | EPS | $0.00 | |||
| Volume | 4,941,532 | |||||
